Chinese General Practice ›› 2023, Vol. 26 ›› Issue (32): 4013-4019.DOI: 10.12114/j.issn.1007-9572.2023.0175
Special Issue: 内分泌代谢性疾病最新文章合辑
• Article • Previous Articles Next Articles
Received:
2023-03-22
Revised:
2023-05-23
Published:
2023-11-15
Online:
2023-05-31
Contact:
MA Qiang
通讯作者:
马强
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0175
组别 | 例数 | 性别〔例(%)〕 | 年龄〔M(P25,P75),岁〕 | BMI〔M(P25,P75),kg/m2〕 | 独居〔例(%)〕 | 糖尿病病程〔M(P25,P75),年〕 | 吸烟史〔例(%)〕 | |
---|---|---|---|---|---|---|---|---|
男 | 女 | |||||||
复发组 | 116 | 55(47.4) | 61(52.6) | 57.0(53.0,65.0) | 22.5(21.5,23.0) | 55(47.4) | 11(10.0,12.0) | 33(28.4) |
未复发组 | 274 | 153(55.8) | 121(44.2) | 58.0(52.0,65.0) | 23.0(22.0,24.5) | 97(35.4) | 9(8.0,11.0) | 115(42.0) |
检验统计量值 | 2.325 | -0.247a | -5.660a | 4.944 | -6.802a | 6.329 | ||
P值 | 0.151 | 0.805 | <0.001 | 0.026 | <0.001 | 0.012 | ||
组别 | 饮酒史〔例(%)〕 | 受累足趾截肢史〔例(%)〕 | 溃疡因创伤引起〔例(%)〕 | 足溃疡分级〔例(%)〕 | ||||
Ⅰ级 | Ⅱ级 | Ⅲ级 | Ⅳ级 | Ⅴ级 | ||||
复发组 | 35(30.2) | 63(54.3) | 55(47.4) | 4(3.4) | 17(14.7) | 43(37.0) | 35(30.2) | 17(14.7) |
未复发组 | 127(46.4) | 75(27.4) | 112(40.9) | 62(22.6) | 88(32.1) | 74(27.0) | 43(15.7) | 7(2.6) |
检验统计量值 | 8.784 | 25.866 | 1.423 | 57.628b | ||||
P值 | 0.003 | <0.001 | 0.233 | <0.001 | ||||
组别 | 踝肱指数〔例(%)〕 | 溃疡位置在脚底〔例(%)〕 | 足部胼胝〔例(%)〕 | 足趾受累〔例(%)〕 | 足部存在行走障碍〔例(%)〕 | 骨髓炎〔例(%)〕 | ||
差 | 良 | |||||||
复发组 | 48(41.4) | 68(58.6) | 66(56.9) | 37(31.9) | 57(49.1) | 91(78.4) | 55(47.4) | |
未复发组 | 68(24.8) | 206(75.2) | 92(33.6) | 76(27.7) | 83(30.3) | 157(57.3) | 95(34.7) | |
检验统计量值 | 10.697 | 18.390 | 0.685 | 12.679 | 15.744 | 5.591 | ||
P值 | <0.001 | <0.001 | 0.408 | <0.001 | <0.001 | 0.018 | ||
组别 | 多重耐药菌感染〔例(%)〕 | 下肢动脉粥样硬化〔例(%)〕 | 糖尿病周围神经病变〔例(%)〕 | 糖化血红蛋白〔M(P25,P75),%〕 | 足部自我管理行为〔M(P25,P75),分〕 | DFUs风险感知水平〔M(P25,P75),分〕 | ||
复发组 | 70(60.3) | 51(44.0) | 57(49.1) | 8.5(7.6,9.4) | 18.45(16.31,22.37) | 34.52(31.31,39.58) | ||
未复发组 | 85(31.0) | 75(27.4) | 92(33.6) | 7.5(7.2,8.4) | 22.80(20.33,25.49) | 40.58(37.72,43.36) | ||
检验统计量值 | 29.261 | 10.260 | 8.359 | -6.911a | -8.077a | -6.768a | ||
P值 | <0.001 | <0.001 | 0.004 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of general information between the two groups of patients with DFUs
组别 | 例数 | 性别〔例(%)〕 | 年龄〔M(P25,P75),岁〕 | BMI〔M(P25,P75),kg/m2〕 | 独居〔例(%)〕 | 糖尿病病程〔M(P25,P75),年〕 | 吸烟史〔例(%)〕 | |
---|---|---|---|---|---|---|---|---|
男 | 女 | |||||||
复发组 | 116 | 55(47.4) | 61(52.6) | 57.0(53.0,65.0) | 22.5(21.5,23.0) | 55(47.4) | 11(10.0,12.0) | 33(28.4) |
未复发组 | 274 | 153(55.8) | 121(44.2) | 58.0(52.0,65.0) | 23.0(22.0,24.5) | 97(35.4) | 9(8.0,11.0) | 115(42.0) |
检验统计量值 | 2.325 | -0.247a | -5.660a | 4.944 | -6.802a | 6.329 | ||
P值 | 0.151 | 0.805 | <0.001 | 0.026 | <0.001 | 0.012 | ||
组别 | 饮酒史〔例(%)〕 | 受累足趾截肢史〔例(%)〕 | 溃疡因创伤引起〔例(%)〕 | 足溃疡分级〔例(%)〕 | ||||
Ⅰ级 | Ⅱ级 | Ⅲ级 | Ⅳ级 | Ⅴ级 | ||||
复发组 | 35(30.2) | 63(54.3) | 55(47.4) | 4(3.4) | 17(14.7) | 43(37.0) | 35(30.2) | 17(14.7) |
未复发组 | 127(46.4) | 75(27.4) | 112(40.9) | 62(22.6) | 88(32.1) | 74(27.0) | 43(15.7) | 7(2.6) |
检验统计量值 | 8.784 | 25.866 | 1.423 | 57.628b | ||||
P值 | 0.003 | <0.001 | 0.233 | <0.001 | ||||
组别 | 踝肱指数〔例(%)〕 | 溃疡位置在脚底〔例(%)〕 | 足部胼胝〔例(%)〕 | 足趾受累〔例(%)〕 | 足部存在行走障碍〔例(%)〕 | 骨髓炎〔例(%)〕 | ||
差 | 良 | |||||||
复发组 | 48(41.4) | 68(58.6) | 66(56.9) | 37(31.9) | 57(49.1) | 91(78.4) | 55(47.4) | |
未复发组 | 68(24.8) | 206(75.2) | 92(33.6) | 76(27.7) | 83(30.3) | 157(57.3) | 95(34.7) | |
检验统计量值 | 10.697 | 18.390 | 0.685 | 12.679 | 15.744 | 5.591 | ||
P值 | <0.001 | <0.001 | 0.408 | <0.001 | <0.001 | 0.018 | ||
组别 | 多重耐药菌感染〔例(%)〕 | 下肢动脉粥样硬化〔例(%)〕 | 糖尿病周围神经病变〔例(%)〕 | 糖化血红蛋白〔M(P25,P75),%〕 | 足部自我管理行为〔M(P25,P75),分〕 | DFUs风险感知水平〔M(P25,P75),分〕 | ||
复发组 | 70(60.3) | 51(44.0) | 57(49.1) | 8.5(7.6,9.4) | 18.45(16.31,22.37) | 34.52(31.31,39.58) | ||
未复发组 | 85(31.0) | 75(27.4) | 92(33.6) | 7.5(7.2,8.4) | 22.80(20.33,25.49) | 40.58(37.72,43.36) | ||
检验统计量值 | 29.261 | 10.260 | 8.359 | -6.911a | -8.077a | -6.768a | ||
P值 | <0.001 | <0.001 | 0.004 | <0.001 | <0.001 | <0.001 |
变量 | 赋值 |
---|---|
DFUs复发 | 是=1,否=0 |
BMI | 实测值 |
独居 | 是=1,否=0 |
糖尿病病程 | 实测值 |
吸烟史 | 有=1,无=0 |
饮酒史 | 有=1,无=0 |
受累足趾截肢史 | 有=1,无=0 |
足溃疡分级 | Ⅰ级=1,Ⅱ级=2,Ⅲ级=3,Ⅳ级=4,Ⅴ级=5 |
踝肱指数 | 良=0,差=1 |
糖化血红蛋白 | 实测值 |
溃疡位置在脚底 | 是=1,否=0 |
足趾受累 | 是=1,否=0 |
足部存在行走障碍 | 是=1,否=0 |
骨髓炎 | 有=1,无=0 |
多重耐药菌感染 | 有=1,无=0 |
下肢动脉粥样硬化 | 有=1,无=0 |
糖尿病周围神经病变 | 有=1,无=0 |
足部自我管理行为 | 实测值 |
DFUs风险感知水平 | 实测值 |
Table 2 Assignment table for multivariable Logistic regression analysis of influencing factors of DFUs recurrence
变量 | 赋值 |
---|---|
DFUs复发 | 是=1,否=0 |
BMI | 实测值 |
独居 | 是=1,否=0 |
糖尿病病程 | 实测值 |
吸烟史 | 有=1,无=0 |
饮酒史 | 有=1,无=0 |
受累足趾截肢史 | 有=1,无=0 |
足溃疡分级 | Ⅰ级=1,Ⅱ级=2,Ⅲ级=3,Ⅳ级=4,Ⅴ级=5 |
踝肱指数 | 良=0,差=1 |
糖化血红蛋白 | 实测值 |
溃疡位置在脚底 | 是=1,否=0 |
足趾受累 | 是=1,否=0 |
足部存在行走障碍 | 是=1,否=0 |
骨髓炎 | 有=1,无=0 |
多重耐药菌感染 | 有=1,无=0 |
下肢动脉粥样硬化 | 有=1,无=0 |
糖尿病周围神经病变 | 有=1,无=0 |
足部自我管理行为 | 实测值 |
DFUs风险感知水平 | 实测值 |
自变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
常量 | 18.018 | 4.174 | 18.636 | <0.001 | — | — |
BMI | -0.931 | 0.166 | 31.337 | <0.001 | 0.394 | (0.285,0.546) |
独居 | -0.562 | 0.412 | 1.861 | 0.173 | 0.570 | (0.255,1.278) |
糖尿病病程 | 0.492 | 0.116 | 18.050 | <0.001 | 1.635 | (1.303,2.051) |
吸烟史 | -1.679 | 0.431 | 15.209 | <0.001 | 0.186 | (0.080,0.434) |
饮酒史 | -0.489 | 0.401 | 1.490 | 0.222 | 0.613 | (0.279,1.345) |
受累足趾截肢史 | 0.402 | 0.483 | 0.693 | 0.405 | 1.495 | (0.580,3.853) |
足溃疡分级 | 0.760 | 0.324 | 5.497 | 0.019 | 2.139 | (1.133,4.038) |
踝肱指数 | -0.093 | 0.519 | 0.032 | 0.858 | 0.911 | (0.329,2.521) |
糖化血红蛋白 | 0.828 | 0.221 | 14.081 | <0.001 | 2.289 | (1.485,3.528) |
溃疡位置在脚底 | 1.147 | 0.434 | 6.972 | 0.008 | 3.148 | (1.344,7.373) |
足趾受累 | 0.032 | 0.470 | 0.005 | 0.946 | 1.032 | (0.411,2.596) |
足部存在行走障碍 | -0.408 | 0.541 | 0.568 | 0.451 | 0.665 | (0.231,1.920) |
骨髓炎 | -0.938 | 0.587 | 2.555 | 0.110 | 0.391 | (0.124,1.236) |
多重耐药菌感染 | -0.119 | 0.174 | 0.464 | 0.496 | 0.888 | (0.632,1.249) |
下肢动脉粥样硬化 | 0.110 | 0.452 | 0.059 | 0.808 | 1.116 | (0.460,2.705) |
糖尿病周围神经病变 | -0.311 | 0.600 | 0.270 | 0.604 | 0.732 | (0.226,2.372) |
足部自我管理行为 | -0.296 | 0.051 | 33.509 | <0.001 | 0.744 | (0.673,0.822) |
DFUs风险感知水平 | -0.114 | 0.028 | 16.686 | <0.001 | 0.892 | (0.845,0.942) |
Table 3 Multivariable Logistic regression analysis of influencing factors of DFUs recurrence
自变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
常量 | 18.018 | 4.174 | 18.636 | <0.001 | — | — |
BMI | -0.931 | 0.166 | 31.337 | <0.001 | 0.394 | (0.285,0.546) |
独居 | -0.562 | 0.412 | 1.861 | 0.173 | 0.570 | (0.255,1.278) |
糖尿病病程 | 0.492 | 0.116 | 18.050 | <0.001 | 1.635 | (1.303,2.051) |
吸烟史 | -1.679 | 0.431 | 15.209 | <0.001 | 0.186 | (0.080,0.434) |
饮酒史 | -0.489 | 0.401 | 1.490 | 0.222 | 0.613 | (0.279,1.345) |
受累足趾截肢史 | 0.402 | 0.483 | 0.693 | 0.405 | 1.495 | (0.580,3.853) |
足溃疡分级 | 0.760 | 0.324 | 5.497 | 0.019 | 2.139 | (1.133,4.038) |
踝肱指数 | -0.093 | 0.519 | 0.032 | 0.858 | 0.911 | (0.329,2.521) |
糖化血红蛋白 | 0.828 | 0.221 | 14.081 | <0.001 | 2.289 | (1.485,3.528) |
溃疡位置在脚底 | 1.147 | 0.434 | 6.972 | 0.008 | 3.148 | (1.344,7.373) |
足趾受累 | 0.032 | 0.470 | 0.005 | 0.946 | 1.032 | (0.411,2.596) |
足部存在行走障碍 | -0.408 | 0.541 | 0.568 | 0.451 | 0.665 | (0.231,1.920) |
骨髓炎 | -0.938 | 0.587 | 2.555 | 0.110 | 0.391 | (0.124,1.236) |
多重耐药菌感染 | -0.119 | 0.174 | 0.464 | 0.496 | 0.888 | (0.632,1.249) |
下肢动脉粥样硬化 | 0.110 | 0.452 | 0.059 | 0.808 | 1.116 | (0.460,2.705) |
糖尿病周围神经病变 | -0.311 | 0.600 | 0.270 | 0.604 | 0.732 | (0.226,2.372) |
足部自我管理行为 | -0.296 | 0.051 | 33.509 | <0.001 | 0.744 | (0.673,0.822) |
DFUs风险感知水平 | -0.114 | 0.028 | 16.686 | <0.001 | 0.892 | (0.845,0.942) |
评价指标 | 训练集 | 测试集 | ||||
---|---|---|---|---|---|---|
Logistic回归模型 | SVM模型 | BPNN模型 | Logistic回归模型 | SVM模型 | BPNN模型 | |
查准率(%) | 85.26 | 95.30 | 88.36 | 85.42 | 97.06 | 90.06 |
召回率(%) | 82.74 | 89.79 | 68.40 | 82.94 | 88.19 | 65.83 |
正确率(%) | 84.41 | 96.53 | 90.64 | 82.43 | 94.87 | 87.17 |
F1指数 | 0.85 | 0.97 | 0.94 | 0.84 | 0.96 | 0.91 |
AUC | 0.855 | 0.943 | 0.837 | 0.843 | 0.937 | 0.820 |
灵敏度 | 0.97 | 0.99 | 0.98 | 0.97 | 0.99 | 0.99 |
特异度 | 0.84 | 0.92 | 0.78 | 0.81 | 0.87 | 0.75 |
Table 4 Comparison of predictive performance of Logistic regression,SVM and BPNN recurrence risk prediction models for DFUs
评价指标 | 训练集 | 测试集 | ||||
---|---|---|---|---|---|---|
Logistic回归模型 | SVM模型 | BPNN模型 | Logistic回归模型 | SVM模型 | BPNN模型 | |
查准率(%) | 85.26 | 95.30 | 88.36 | 85.42 | 97.06 | 90.06 |
召回率(%) | 82.74 | 89.79 | 68.40 | 82.94 | 88.19 | 65.83 |
正确率(%) | 84.41 | 96.53 | 90.64 | 82.43 | 94.87 | 87.17 |
F1指数 | 0.85 | 0.97 | 0.94 | 0.84 | 0.96 | 0.91 |
AUC | 0.855 | 0.943 | 0.837 | 0.843 | 0.937 | 0.820 |
灵敏度 | 0.97 | 0.99 | 0.98 | 0.97 | 0.99 | 0.99 |
特异度 | 0.84 | 0.92 | 0.78 | 0.81 | 0.87 | 0.75 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
吕静,袁丽,李饶,等. 糖尿病足溃疡复发风险预测模型的构建[J]. 护理研究,2022,36(6):993-998. DOI:10.12102/j.issn.1009-6493.2022.06.009.
|
[6] |
|
[7] |
|
[8] |
American Diabetes Association. Addendum. 9. pharmacologic approaches to glycemic treatment:Standards of medical care in diabetes-2020. diabetes care 2020;43(suppl. 1):S98-110[J]. Diabetes Care,2020,43(8):1979. DOI:10.2337/dc20-ad08a.
|
[9] |
李柏樟. 白癜风共病糖尿病风险预测模型的构建及验证[D]. 西安:空军军医大学,2022.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
方蕾. 慢性病病人风险感知问卷的编制及其影响因素研究[D]. 西安:第四军医大学,2015.
|
[14] |
马倩倩,孙东旭,石金铭,等. 基于支持向量机与XGboost的成年人群肿瘤患病风险预测研究[J]. 中国全科医学,2020,23(12):1486-1491. DOI:10.12114/j.issn.1007-9572.2020.00.066.
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
夏磊,庄若,吴玲,等. 复发性糖尿病足溃疡相关危险因素的Meta分析[J]. 中华现代护理杂志,2022,28(9):1143-1148. DOI:10.3760/cma.j.cn115682-20210802-03422.
|
[20] |
周罗晶,刘昕,高巨. 无痛结肠镜检查术患者术后疲劳综合征人工神经网络预测模型的建立[J]. 中华麻醉学杂志,2021,41(4):397-400. DOI:10.3760/cma.j.cn131073.20201202.00403.
|
[21] |
吴秋硕,陆宗庆,刘瑜,等. 2010至2020年机器学习方法在重症医学领域应用进展的可视化分析[J]. 中国急救医学,2021,41(11):959-965. DOI:10.3969/j.issn.1002-1949.2021.11.008.
|
[22] |
|
[23] |
汪奇,刘尚全. 2型糖尿病患者亚临床动脉粥样硬化的多层人工神经网络分类预测模型的构建[J]. 中国全科医学,2021,24(36):4612-4617. DOI:10.12114/j.issn.1007-9572.2021.00.537.
|
[1] | ZHANG Kexing, ZHANG Bo, WU Qiong, ZHU Shanshan, WANG Di, ZHANG Chunnan. Research on the Mechanism of Action of Simiao Yongan Decoction in the Treatment of Diabetic Foot Based on Metabolomics [J]. Chinese General Practice, 2025, 28(30): 3796-3805. |
[2] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[3] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[4] | ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei. Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy [J]. Chinese General Practice, 2025, 28(26): 3307-3313. |
[5] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[6] | ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270. |
[7] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[8] | TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang. Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3096-3103. |
[9] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[10] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[11] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[12] | LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin. Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2852-2860. |
[13] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
[14] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
[15] | WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei. Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(23): 2846-2851. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||